Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas
Zofia Wotschofsky(Charité - Universitätsmedizin Berlin), Klaus Jung(University of Veterinary Medicine Hannover, Foundation), I. Melcher(Charité - Universitätsmedizin Berlin), Julia Liep(Ecologic Institute), Alexander C. Disch(University Hospital Carl Gustav Carus), Andreas Erbersdobler(Universitätsmedizin Rostock), Ina Wagner(Max Planck Institute for Infection Biology), Ergin Kilic(Istanbul Technical University), Hellmuth‐Alexander Meyer(Charité - Universitätsmedizin Berlin), Monika Jung(Charité - Universitätsmedizin Berlin), Kurt Miller(Charité - Universitätsmedizin Berlin), Steffen Weikert(St. Hedwig-Krankenhaus), Jonas Busch(Charité - Universitätsmedizin Berlin), K.-D. Schaser(Charité - Universitätsmedizin Berlin), Hans‐Joachim Mollenkopf(Max Planck Institute for Infection Biology)
Cited by 89
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
|International Journal of Cancer|2009|613